Perpetua Medical AB (publ)

OM:PERP B Stock Report

Market Cap: SEK 19.6m

Perpetua Medical Past Earnings Performance

Past criteria checks 0/6

Perpetua Medical has been growing earnings at an average annual rate of 3.1%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 25.5% per year.

Key information

3.1%

Earnings growth rate

30.0%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate25.5%
Return on equity-42.9%
Net Margin-96.9%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Perpetua Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:PERP B Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245-5140
30 Jun 246-8170
31 Mar 247-12210
31 Dec 2310-18240
30 Sep 239-21260
30 Jun 2311-20260
31 Mar 2313-19270
31 Dec 2210-19260
30 Sep 2212-15230
30 Jun 2211-16230
31 Mar 228-16210
31 Dec 219-14190
30 Sep 216-15180
30 Jun 214-14170
31 Mar 214-13150
31 Dec 202-15160
30 Sep 201-16150
30 Jun 201-16150
31 Mar 202-17160
31 Dec 192-17150
30 Sep 193-14150
30 Jun 193-14140
31 Mar 191-14130
31 Dec 181-12120
30 Sep 181-12110
30 Jun 181-11110
31 Mar 181-10100
31 Dec 171-1090
30 Sep 170-11100
30 Jun 170-11100
31 Mar 170-12100
31 Dec 160-11100
30 Sep 160-1080
30 Jun 160-1080
31 Mar 160-970
31 Dec 150-760
30 Sep 151-550
30 Jun 151-340
31 Mar 151-230
31 Dec 141-120
31 Dec 131-210

Quality Earnings: PERP B is currently unprofitable.

Growing Profit Margin: PERP B is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PERP B is unprofitable, but has reduced losses over the past 5 years at a rate of 3.1% per year.

Accelerating Growth: Unable to compare PERP B's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PERP B is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: PERP B has a negative Return on Equity (-42.9%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:39
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Perpetua Medical AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Niklas ElmhammerCarlsquare AB